| Target Price | $134.64 |
| Price | $104.94 |
| Potential |
28.30%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target Kimberly-Clark 2026 .
The average Kimberly-Clark target price is $134.64.
This is
28.30%
register free of charge
$170.10
62.09%
register free of charge
$101.00
3.75%
register free of charge
|
|
| A rating was issued by 24 analysts: 9 Analysts recommend Kimberly-Clark to buy, 14 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Kimberly-Clark stock has an average upside potential 2026 of
28.30%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 20.06 | 16.96 |
| 1.83% | 15.45% | |
| EBITDA Margin | 22.65% | 21.53% |
| 24.72% | 4.96% | |
| Net Margin | 12.69% | 14.63% |
| 46.96% | 15.30% |
21 Analysts have issued a sales forecast Kimberly-Clark 2025 . The average Kimberly-Clark sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Kimberly-Clark EBITDA forecast 2025. The average Kimberly-Clark EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
21 Kimberly-Clark Analysts have issued a net profit forecast 2025. The average Kimberly-Clark net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 7.55 | 7.48 |
| 44.91% | 0.93% | |
| P/E | 14.19 | |
| EV/Sales | 2.47 |
21 Analysts have issued a Kimberly-Clark forecast for earnings per share. The average Kimberly-Clark EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BNP Paribas Exane |
Locked
➜
Locked
|
Locked | Dec 01 2025 |
| Argus Research |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Oct 31 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BNP Paribas Exane:
Locked
➜
Locked
|
Dec 01 2025 |
|
Locked
Argus Research:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Oct 31 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


